Your browser doesn't support javascript.
Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets.
Harmon, Stephanie A; Sanford, Thomas H; Xu, Sheng; Turkbey, Evrim B; Roth, Holger; Xu, Ziyue; Yang, Dong; Myronenko, Andriy; Anderson, Victoria; Amalou, Amel; Blain, Maxime; Kassin, Michael; Long, Dilara; Varble, Nicole; Walker, Stephanie M; Bagci, Ulas; Ierardi, Anna Maria; Stellato, Elvira; Plensich, Guido Giovanni; Franceschelli, Giuseppe; Girlando, Cristiano; Irmici, Giovanni; Labella, Dominic; Hammoud, Dima; Malayeri, Ashkan; Jones, Elizabeth; Summers, Ronald M; Choyke, Peter L; Xu, Daguang; Flores, Mona; Tamura, Kaku; Obinata, Hirofumi; Mori, Hitoshi; Patella, Francesca; Cariati, Maurizio; Carrafiello, Gianpaolo; An, Peng; Wood, Bradford J; Turkbey, Baris.
  • Harmon SA; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sanford TH; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Xu S; State University of New York-Upstate Medical Center, Syracuse, NY, USA.
  • Turkbey EB; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Roth H; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Xu Z; NVIDIA Corporation, Bethesda, MD, USA.
  • Yang D; NVIDIA Corporation, Bethesda, MD, USA.
  • Myronenko A; NVIDIA Corporation, Bethesda, MD, USA.
  • Anderson V; NVIDIA Corporation, Bethesda, MD, USA.
  • Amalou A; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Blain M; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Kassin M; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Long D; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Varble N; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Walker SM; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Bagci U; Philips Research North America, Cambridge, MA, USA.
  • Ierardi AM; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Stellato E; Center for Research in Computer Vision, University of Central Florida, Orlando, FL, USA.
  • Plensich GG; Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Franceschelli G; Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Girlando C; Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Irmici G; Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy.
  • Labella D; Postgraduation School in Radiodiagnostics, Università Degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.
  • Hammoud D; Postgraduation School in Radiodiagnostics, Università Degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.
  • Malayeri A; State University of New York-Upstate Medical Center, Syracuse, NY, USA.
  • Jones E; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Summers RM; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Choyke PL; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Xu D; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Flores M; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Tamura K; NVIDIA Corporation, Bethesda, MD, USA.
  • Obinata H; NVIDIA Corporation, Bethesda, MD, USA.
  • Mori H; Self-Defense Forces Central Hospital, Tokyo, Japan.
  • Patella F; Self-Defense Forces Central Hospital, Tokyo, Japan.
  • Cariati M; Self-Defense Forces Central Hospital, Tokyo, Japan.
  • Carrafiello G; Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy.
  • An P; Diagnostic and Interventional Radiology Service, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy.
  • Wood BJ; Department of Radiology Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Milan, Italy.
  • Turkbey B; Department of Health Sciences, University of Milano, Milan, Italy.
Nat Commun ; 11(1): 4080, 2020 08 14.
Article in English | MEDLINE | ID: covidwho-717116
ABSTRACT
Chest CT is emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease. Artificial intelligence (AI) has the potential to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings from other clinical entities. Here we show that a series of deep learning algorithms, trained in a diverse multinational cohort of 1280 patients to localize parietal pleura/lung parenchyma followed by classification of COVID-19 pneumonia, can achieve up to 90.8% accuracy, with 84% sensitivity and 93% specificity, as evaluated in an independent test set (not included in training and validation) of 1337 patients. Normal controls included chest CTs from oncology, emergency, and pneumonia-related indications. The false positive rate in 140 patients with laboratory confirmed other (non COVID-19) pneumonias was 10%. AI-based algorithms can readily identify CT scans with COVID-19 associated pneumonia, as well as distinguish non-COVID related pneumonias with high specificity in diverse patient populations.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Artificial Intelligence / Tomography, X-Ray Computed / Coronavirus Infections / Clinical Laboratory Techniques Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-17971-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Artificial Intelligence / Tomography, X-Ray Computed / Coronavirus Infections / Clinical Laboratory Techniques Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-17971-2